Description
Buy Digoxin 125 mcg Tablets Online
Buyย Digoxinย 250 mcg Tablets Online
Where to Buy Lanoxin Tabletsย (Digoxin Tablets) Online?
You can order and getย Lanoxin tablets (Digoxin tablets) safely from this site. We are the only reliable and legit online vendor of Digoxin, pentobarbital (sodium) and other barbiturates. We offer genuine and best quality Digoxin tablets at reasonable costs. Fast and Discreet Worldwide shipping.
Also available on our website Nembutal Sodium Oral Solution, Nembutal Sodium Pills, Nembutal Sodium Oral Soluble Powder, Nembutal Sodium Raw Powder and other barbiturates.
What is Lanoxin (Digoxin)?
LANOXIN (digoxin) is a cardiac glycoside, a closely related group of drugs having in common specific effects on theย myocardium. These drugs are found in a number of plants. Digoxin is extracted from the leaves of Digitalis lanata.
LANOXIN is supplied as 125 mcg (0.125-mg) or 250 mcg (0.25-mg) tablets for oral administration. Each tablet contains the labeled amount of digoxin USP and the following inactive ingredients: corn and potato starches, lactose, and magnesium stearate. In addition, the dyes used in the 125 mcg (0.125 mg) tablets are D&C Yellow No. 10 and FD&C Yellow No. 6.
Indications and Dosage
Indications
Heart Failure in Adults
LANOXIN is indicated for the treatment of mild to moderate heart failure in adults. LANOXIN increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by improved exercise capacity and decreased heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, LANOXIN should be used in combination with aย diureticย and an angiotensin-converting enzyme (ACE) inhibitor.
Heart Failure in Pediatric Patients
LANOXIN increases myocardial contractility in pediatric patients with heart failure.
Atrial Fibrillation in Adults
LANOXIN is indicated for the control of ventricular response rate in adult patients with chronic atrial fibrillation.
Dosage and Administration
Important Dosing Information
In selecting a LANOXIN dosing regimen, it is important to consider factors that affect digoxin blood levels (e.g., body weight, age, renal function, concomitant drugs) since toxic levels of digoxin are only slightly higher than therapeutic levels. Dosing can be either initiated with a loading dose followed by maintenance dosing if rapid titration is desired or initiated with maintenance dosing without a loading dose.
Consider interruption or reduction in digoxin dose prior to electrical cardioversion.
Useย digoxinย solution to obtain the appropriate dose in infants, young pediatric patients, or patients with very low body weight.
Loading Dosing Regimen in Adults and Pediatric Patients
For adults and pediatric patients if a loading dosage is to be given, administer half the total loading dose initially, then ยผ the loading dose every 4 to 8 hours twice, with careful assessment of clinical response and toxicity before each dose. The recommended loading dose is displayed in Table 1.
Table 1: Recommended LANOXIN Oral Loading Dose
Age |
Oral Loading Dose, mcg/kg |
5 to 10 years |
20 -45 |
Adults and pediatric patients over 10 years |
10-15 |
mcg = micrograms |
Maintenance Dosing in Adults and Pediatric Patients Over 10 Years Old
The maintenance dose is based on the lean body weight, renal function, age, and concomitant products.
The recommended starting maintenance dosage in adults and pediatric patients over 10 years old is displayed in Table 2. Doses may be increased every 2 weeks according to clinical response, serum drug levels, and toxicity.
Table 2: Recommended Starting LANOXIN Maintenance Dosage in Adults and Pediatric Patients Over 10 Years Old
Age |
Oral Maintenance Dose, mcg/kg/day (given once daily) |
Adults and pediatric patients over 10 years |
3.4 โ 5.1 |
mcg = micrograms |
Table 3 displays the recommended (once daily) maintenance dose of LANOXIN in pediatric patients over 10 years old and adult patients according to lean body weight and renal function. The doses are based on studies in adult patients with heart failure. Alternatively, the maintenance dose may be estimated by the following formula (peak body stores lost each day through elimination):
Total Maintenance Dose = Loading Dose (i.e., Peak Body Stores) x % Daily Loss/100
(% Daily Loss = 14 + Creatinine clearance/5)
Reduce the dose of LANOXIN in patients whose lean weight is an abnormally small fraction of their total body mass because ofย obesityย or edema.
Table 3: Recommended Maintenance Dose (in micrograms given once daily) of LANOXIN in Pediatric Patients Over 10 Years Old and Adults by Lean Body Weight and by Renal Functiona
Maintenance Dosing in Pediatric Patients Less Than 10 Years Old |
The starting maintenance dose for heart failure in pediatric patients less than 10 years old is based on the lean body weight, renal function, age, and concomitant products.
The recommended starting maintenance dose for pediatric patients between 5 and 10 years old with normal renal function is displayed in Table 4.
Table 4: Recommended Starting LANOXIN Maintenance Dosage in Pediatric Patients Between 5 and 10 Years Old
Age |
Daily Oral Maintenance Dose, mcg/kg/day |
Dose Regimen, mcg/kg/dose |
5 to 10 years |
6.4 โ 12.9 |
3.2 โ 6.4 Twice daily |
The recommended maintenance dose (to be given twice daily) is presented in Table 5.
Table 5: Recommended Maintenance Dose (in micrograms given twice daily) of LANOXIN in Pediatric Patients < 10 Years of Ageaย Based upon Lean Body Weight and Renal Functiona,b
|
Monitor for signs and symptoms of digoxin toxicity and clinical response. Adjust dose based on toxicity, efficacy, and blood levels.
Serum digoxin levels < 0.5 ng/mL have been associated with diminished efficacy, while levels above 2 ng/mL have been associated with increased toxicity without increased benefit.
Interpret the serum digoxin concentration in the overall clinical context, and do not use an isolated measurement of serum digoxin concentration as the basis for increasing or decreasing the LANOXIN dose. Serum digoxin concentrations may be falsely elevated by endogenous digoxin-like substances.
If the assay is sensitive to these substances, consider obtaining a baseline digoxin level before starting LANOXIN and correct post-treatment values by the reported baseline level.
Obtain serum digoxin concentrations just before the next scheduled LANOXIN dose or at least 6 hours after the last dose. The digoxin concentration is likely to be 10% to 25% lower when sampled right before the next dose (24 hours after dosing) compared to sampling 8 hours after dosing (using once-daily dosing). However, there will be only minor differences in digoxin concentrations using twice daily dosing whether sampling is done at 8 or 12 hours after a dose.
Switching from Intravenous Digoxin to Oral Digoxin
When switching from intravenous to oral digoxin formulations, make allowances for differences in bioavailability when calculating maintenance dosages (see Table 6).
Table 6: Comparison of the Systemic Availability and Equivalent Doses of Oral and Intravenous LANOXIN
ย |
Absolute Bioavailability |
Equivalent Doses (in micrograms) |
|||
LANOXIN Tablets |
60 -80% |
62.5 |
125 |
250 |
500 |
LANOXIN Intravenous Injection |
100% |
50 |
100 |
200 |
400 |
HOW SUPPLIED
Dosage Forms And Strengths
Tablets: 125 micrograms are yellow, round, scored tablets with โY3Bโ imprinted on one side. Tablets: 250 micrograms are white, round, scored tablets with โX3Aโ imprinted on one side.
Storage And Handling
LANOXIN (digoxin) Tablets, Scored 125 mcg (0.125 mg): Bottles of 100 with child-resistant cap (NDCย 0173-0242-55) and 1,000 (NDCย 0173-0242-75); unit dose pack of 100 (NDCย 01730242-56). Imprinted with LANOXIN and Y3B (yellow).
LANOXIN (digoxin) Tablets, Scored 250 mcg (0.25 mg): Bottles of 100 with child-resistant cap (NDC0173-0249-55), 1,000 (NDCย 0173-0249-75), and 5,000 (NDCย 0173-0249-80); unit dose pack of 100 (NDCย 0173-0249-5656). Imprinted with LANOXIN and X3A (white).
Store at 25ยฐC (77ยฐF); excursions permitted to 15 to 30ยฐC (59 to 86ยฐF) in a dry place and protect from light. Keep out of reach of children.
Reviews
There are no reviews yet.